schliessen

Filtern

 

Bibliotheken

SendSend as email Add to Book BagAdd to Book Bag
Staff View
recordid: proquest734123250
title: Pemetrexed approved for the first-line treatment of non-small-cell lung cancer: summary of the NICE appraisal.
format: Article
creator:
  • Vrouchou, Panagiota
  • Kandaswamy, Prashanth
  • George, Elisabeth
  • Barnett, David
subjects:
  • Antimetabolites, Antineoplastic–Administration & Dosage
  • Antineoplastic Combined Chemotherapy Protocols–Economics
  • Carcinoma, Non-Small-Cell Lung–Economics
  • Cisplatin–Therapeutic Use
  • Cost-Benefit Analysis–Drug Therapy
  • Drug Approval–Economics
  • Drug Costs–Administration & Dosage
  • Glutamates–Administration & Dosage
  • Guanine–Economics
  • Humans–Administration & Dosage
  • Lung Neoplasms–Analogs & Derivatives
  • Pemetrexed–Economics
  • Practice Guidelines As Topic–Drug Therapy
  • Treatment Outcome–Economics
  • United Kingdom–Economics
  • Antimetabolites, Antineoplastic
  • Glutamates
  • Pemetrexed
  • Guanine
  • Cisplatin
ispartof: The Lancet. Oncology, November 2009, Vol.10(11), pp.1031-1032
description:
language: eng
source:
identifier: E-ISSN: 1474-5488
fulltext: fulltext
issn:
  • 14745488
  • 1474-5488
url: Link


@attributes
ID13272916
RANK0.07
NO1
SEARCH_ENGINEprimo_central_multiple_fe
SEARCH_ENGINE_TYPEPrimo Central Search Engine
LOCALfalse
PrimoNMBib
record
control
sourcerecordid734123250
sourceidproquest
recordidTN_proquest734123250
sourcesystemPC
pqid734123250
display
typearticle
titlePemetrexed approved for the first-line treatment of non-small-cell lung cancer: summary of the NICE appraisal.
creatorVrouchou, Panagiota ; Kandaswamy, Prashanth ; George, Elisabeth ; Barnett, David
contributorVrouchou, Panagiota (correspondence author) ; Vrouchou, Panagiota (record owner)
ispartofThe Lancet. Oncology, November 2009, Vol.10(11), pp.1031-1032
identifierE-ISSN: 1474-5488
subjectAntimetabolites, Antineoplastic–Administration & Dosage ; Antineoplastic Combined Chemotherapy Protocols–Economics ; Carcinoma, Non-Small-Cell Lung–Economics ; Cisplatin–Therapeutic Use ; Cost-Benefit Analysis–Drug Therapy ; Drug Approval–Economics ; Drug Costs–Administration & Dosage ; Glutamates–Administration & Dosage ; Guanine–Economics ; Humans–Administration & Dosage ; Lung Neoplasms–Analogs & Derivatives ; Pemetrexed–Economics ; Practice Guidelines As Topic–Drug Therapy ; Treatment Outcome–Economics ; United Kingdom–Economics ; Antimetabolites, Antineoplastic ; Glutamates ; Pemetrexed ; Guanine ; Cisplatin
languageeng
source
version2
lds50peer_reviewed
links
openurl$$Topenurl_article
openurlfulltext$$Topenurlfull_article
backlink$$Uhttp://search.proquest.com/docview/734123250/?pq-origsite=primo$$EView_record_in_ProQuest_(subscribers_only)
search
creatorcontrib
0Vrouchou, Panagiota
1Kandaswamy, Prashanth
2George, Elisabeth
3Barnett, David
titlePemetrexed approved for the first-line treatment of non-small-cell lung cancer: summary of the NICE appraisal.
subject
0Antimetabolites, Antineoplastic–Administration & Dosage
1Antineoplastic Combined Chemotherapy Protocols–Economics
2Carcinoma, Non-Small-Cell Lung–Economics
3Cisplatin–Therapeutic Use
4Cost-Benefit Analysis–Drug Therapy
5Drug Approval–Economics
6Drug Costs–Administration & Dosage
7Glutamates–Administration...
general
0English
1MEDLINE (ProQuest)
2ProQuest Biological Science Collection
3ProQuest Environmental Science Collection
4ProQuest Natural Science Collection
5ProQuest SciTech Collection
6Agricultural & Environmental Science Database
7Biological Science Database
8Natural Science Collection
9SciTech Premium Collection
10Health Research Premium Collection
11Health Research Premium Collection (Alumni edition)
12Environmental Science Index (ProQuest)
13Biological Science Index (ProQuest)
14Environmental Science Collection (ProQuest)
sourceidproquest
recordidproquest734123250
issn
014745488
11474-5488
rsrctypenewspaper_article
creationdate2009
addtitleThe Lancet. Oncology
searchscope
01007489
11007527
21007944
31009130
410000004
510000006
610000038
710000043
810000050
910000120
1010000159
1110000198
1210000200
1310000209
1410000217
1510000234
1610000238
1710000253
1810000260
1910000270
2010000271
2110000302
2210000349
2310000350
2410000354
25proquest
scope
01007489
11007527
21007944
31009130
410000004
510000006
610000038
710000043
810000050
910000120
1010000159
1110000198
1210000200
1310000209
1410000217
1510000234
1610000238
1710000253
1810000260
1910000270
2010000271
2110000302
2210000349
2310000350
2410000354
25proquest
lsr43
01007489false
11007527false
21007944false
31009130false
410000004false
510000006false
610000038false
710000043false
810000050false
910000120false
1010000159false
1110000198false
1210000200false
1310000209false
1410000217false
1510000234false
1610000238false
1710000253false
1810000260false
1910000270false
2010000271false
2110000302false
2210000349false
2310000350false
2410000354false
contributorVrouchou, Panagiota
startdate20091101
enddate20091101
citationpf 1031 pt 1032 vol 10 issue 11
lsr30VSR-Enriched:[pqid]
sort
titlePemetrexed approved for the first-line treatment of non-small-cell lung cancer: summary of the NICE appraisal.
authorVrouchou, Panagiota ; Kandaswamy, Prashanth ; George, Elisabeth ; Barnett, David
creationdate20091101
lso0120091101
facets
frbrgroupid6271026343377834260
frbrtype5
newrecords20181218
languageeng
creationdate2009
topic
0Antimetabolites, Antineoplastic–Administration & Dosage
1Antineoplastic Combined Chemotherapy Protocols–Economics
2Carcinoma, Non-Small-Cell Lung–Economics
3Cisplatin–Therapeutic Use
4Cost-Benefit Analysis–Drug Therapy
5Drug Approval–Economics
6Drug Costs–Administration & Dosage
7Glutamates–Administration...
collection
0MEDLINE (ProQuest)
1ProQuest Biological Science Collection
2ProQuest Environmental Science Collection
3ProQuest Natural Science Collection
4ProQuest SciTech Collection
5Agricultural & Environmental Science Database
6Biological Science Database
7Natural Science Collection
8SciTech Premium Collection
9Health Research Premium Collection
10Health Research Premium Collection (Alumni edition)
11Environmental Science Index (ProQuest)
12Biological Science Index (ProQuest)
13Environmental Science Collection (ProQuest)
prefilternewspaper_articles
rsrctypenewspaper_articles
creatorcontrib
0Vrouchou, Panagiota
1Kandaswamy, Prashanth
2George, Elisabeth
3Barnett, David
jtitleLancet. Oncology
toplevelpeer_reviewed
delivery
delcategoryRemote Search Resource
fulltextfulltext
addata
aulast
0Vrouchou
1Kandaswamy
2George
3Barnett
aufirst
0Panagiota
1Prashanth
2Elisabeth
3David
au
0Vrouchou, Panagiota
1Kandaswamy, Prashanth
2George, Elisabeth
3Barnett, David
addauVrouchou, Panagiota
atitlePemetrexed approved for the first-line treatment of non-small-cell lung cancer: summary of the NICE appraisal.
jtitleThe Lancet. Oncology
risdate20091101
volume10
issue11
spage1031
epage1032
pages1031-1032
eissn1474-5488
urlhttp://search.proquest.com/docview/734123250/
date2009-11-01
genrearticle
formatjournal
ristypeJOUR